HHS hammers industry’s attempt to delay new drug price negotiations

Lawyers for HHS on Fri­day sharply crit­i­cized the US Cham­ber of Com­merce’s at­tempt to stall the im­ple­men­ta­tion of new drug pric­ing ne­go­ti­a­tions, set to be­gin on Sept. 1.

While call­ing the busi­ness lob­by­ing group’s claims “hy­per­bol­ic,” the US gov­ern­ment lawyers said the cham­ber is es­sen­tial­ly try­ing to do in court what it failed to do while lob­by­ing Con­gress over the In­fla­tion Re­duc­tion Act that set up these ne­go­ti­a­tions.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.